Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Apr 17, 2009

NEW YORK (GenomeWeb News) - Frank Witney has left his positions at Affymetrix as executive VP and chief commercial officer to serve as president and CEO of the chemical chromatography systems maker Dionex. He replaces Lukas Braunschweiler, who has been president and CEO of Dionex since 2002. Braunschweiler left the post to serve as president and CEO of Ruag Holding.

Witney was president of drug discovery tools at PerkinElmer and he was president and CEO of Panomics before it was purchased last year by Affymetrix.


IO Informatics has added Kathy Gibson to its board of directors. Gibson is president and founder of Helio Consulting and she formerly was chief information officer for research at Pfizer Worldwide.


John Tonkinson has taken the post of VP of global sales and marketing at Protein Forest, a newly created position. Tonkinson previously was VP of business development at HistoRx, he worked in cancer research at Eli Lilly, and he was involved in in vitro and in vivo assay development at Schleicher & Schuell BioSciences.


The American College of Medical Genetics has tapped Bruce Korf to take over the job of president from outgoing President Joe Leigh Simpson. Simpson completed his two-year term in late March.

ACMG also has named six new officers and directors to its board of directors including Wayne Grody of the University of California, Los Angeles School of Medicine; Gregory Grabowski of Cincinnati Children's Hospital; Anthony Gregg of the University of South Carolina School of Medicine; Mira Irons of the Children's Hospital of Boston; John Mulvihill of Oklahoma University Medical Center; and Kathleen Rao of the University of North Carolina.

Three existing board members were elected to new posts. Piero Rinaldo of Mayo Clinic was named VP of laboratory genetics; Marc Williams of Intermountain Healthcare was named VP of clinical genetics; and Daynna Wolff of the Medical University of South Carolina was named treasurer.


Paul Keim will join Febit's scientific advisory board. Keim is senior investigator and director of the pathogen genomics division at the Translational Genomics Research Institute, and he is a professor of Biology at Northern Arizona University. He is an expert in pathogen genomics, biosecurity, and medical microbiology.


Signature Genomic Laboratories has named Trilochan Sahoo to serve as its laboratory director. Sahoo previously was an assistant professor in the department of molecular and human genetics at Baylor College of Medicine, and he completed post-doctoral work at the Government of India Department of Biotechnology and the Duke University Medical Center's departments of Microbiology and Genetics.


RedPath Integrated Pathology has named Mark Myslinski president and CEO. He replaces founding CEO Mary Del Brady, who will remain an active investor in the company. Myslinski formerly was general manager of Johnson & Johnson's Veridex division, and he previously worked at Interscope Technologies, Precision Therapeutics, and Baxter/American Hospital Supply Corporation.


Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People in the News, a weekly roundup of industry comings and goings.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.